Carlsbad, Calif.-based SeaSpine Holdings Corp. expanded the Ventura NanoMetalene posterior interbody device to accommodate a wider range of posterior procedures and patient anatomies.
Here is what you need to know:
1. Ventura NanoMetalene has been commercially available since 2015. The implant's new sizes include additional lengths and oblique placement options with sagittally oriented lordosis.
2. The Ventura interbody devices feature proprietary NanoMetalene surface technology: NanoMetalene is a sub-micron layer of commercially pure titanium bonded at a molecular level to a PEEK implant using a low-temperature, high-energy process known as atomic fusion deposition.
3. NanoMetalene is designed to give implants a bone-friendly titanium surface on endplates and throughout graft apertures while retaining the traditional benefits associated with PEEK implants, including biocompatibility, a modulus of elasticity similar to bone, and good radiographic visibility for postoperative imaging.
4. SeaSpine's entire posterior lumbar NanoMetalene interbody device portfolio is cleared for use in autograft and allograft. Ventura NanoMetalene, along with SeaSpine's new allograft demineralized bone fiber product line, gives surgeons more options for bone grafting.
More articles on surface technology:
PEEK vs. titanium-coated PEEK implants for spinal fusion: 5 key findings
EIT Cellular Titanium implant to enter US market with 510(k) approval — 6 things to know
Titan Spine reports rapid growth, raises $7.5M in series D funding: 6 things to know